Comparative study of two different doses of buprenorphine with bupivacaine in spinal anesthesia in patients undergoing lower abdominal and lower limb surgeries
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2019/04/018414
- Lead Sponsor
- Abi Meenashy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients scheduled for elective lower abdominal and lower limb surgeries in SMVMCH
2. Patients of ASA physical status 1 & 2
3. Patients of either sex
4. Age >18 years or <60 years.
Exclusion Criteria
1. Weight <40kg or >90kg.
2. Body Mass Index >30.
3. Patients having chronic pain and on analgesic medications or with prior history of opioid and other substance abuse.
4. Patients having history of previous spine surgeries, deformity/congenital anomaly of the spine, bleeding disorders.
5. Patients with local site infection, allergy to the drugs that are tested or any other contraindications for regional anaesthesia.
6. Patients who cannot lie down/ non co-operative/ psychiatric illness.
7. Alcoholics.
8. Pregnant / Lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post op analgesia <br/ ><br>Timepoint: Visual analogue scale at 0,10,15,30 and 60 minutes and then at every 30 minutes in post anaesthesia care unit during first 2 hours and then hourly till the next 12 hours in the post operative ward.Whenever VAS score reaches more than 4, rescue analgesia will be given in the form of intramuscular tramadol 50mg. Time to the first dose of tramadol will be recorded.
- Secondary Outcome Measures
Name Time Method Motor blockade <br/ ><br>Sensory blockade <br/ ><br>Timepoint: Motor block is assessed using Modified Bromage scale every 5 min until maximum motor block is achieved and then time of return of normal motor function will be noted.Sensory block will be determined using the pinprick method, dermatomal level will be assessed every 2 minutes from completion of injection until the assessed sensory level remained stable for four consecutive assessments. Testing will be conducted every 10 min thereafter until two-segment regression is noticed.